Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1591295 | 0.80 | TDP1 (0.43) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL27687802 | 0.76 | ALDH1A1 (0.40) | ALDH1A1TDP1GRIK1 | |
| SCHEMBL9116563 | 0.76 | ALDH1A1 (0.36) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL315108 | 0.75 | CHRM1 (0.35) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL27627089 | 0.74 | ALDH1A1 (0.39) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL383081 | 0.72 | OR51E2 (0.39) | ALDH1A1 | |
| SCHEMBL11453097 | 0.71 | SLC22A6 (0.36) | TDP1CYP2C19 | |
| SCHEMBL9830069 | 0.71 | TDP1 (0.36) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL3224348 | 0.70 | CYP2C19 (0.58) | ALDH1A1TDP1CYP2C19 | |
| SCHEMBL11421083 | 0.70 | ALDH1A1 (0.43) | ALDH1A1TDP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115837063-B | Preparation and detection methods of lung force cough pharmaceutical composition | 贵州健兴药业有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-115837063-A | Preparation and detection method of improved lung-strength cough medicine composition | 贵州健兴药业有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-101787059-B | Method for preparing digalactosyl diacylglycerol and application thereof | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2014-10-15 | — | — | CN | disclosed |
| US-8420646-B2 | Tricyclic tetrahydroquinoline antibacterial agents | PAH P&U LLC (US) | 2013-04-16 | — | — | US | disclosed |
| US-20110092494-A1 | Tricyclic Tetrahydroquinoline Antibacterial Agents | PHARMACIA & UPJOHN COMPANY | 2011-04-21 | — | — | US | disclosed |
| CN-101787059-A | Method for preparing digalactosyl diacylglycerol and application thereof | UNIV SHENYANG PHARMACEUTICAL | 2010-07-28 | — | — | CN | disclosed |
| EP-1551849-B1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN CO LLC (US) | 2010-07-14 | — | — | EP | disclosed |
| US-20100022524-A1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY | 2010-01-28 | — | — | US | disclosed |
| CN-100571758-C | Pharmaceutical preparation of treatment infantile anorexia and preparation method thereof and detection method | GUIYANG YUNYAN XICHUANG PHARM (CN) | 2009-12-23 | — | — | CN | disclosed |
| CN-101580524-A | Method for preparing digalactosyldiacylglycerol and application thereof | UNIV SHENYANG PHARMACEUTICAL (CN) | 2009-11-18 | — | — | CN | disclosed |
| CN-1876139-A | Medicinal preparation for treating children's fastidium, its preparation process and quality control method | GUIYANG YUNYAN XICHUANG PHARM (CN) | 2006-12-13 | — | — | CN | disclosed |
| US-20060166202-A1 | Lipid phosphate phosphatases and uses thereof for treating neuronal diseases | CHARITE-UNIVERSITATSMEDIZIN BERLIN (DE) | 2006-07-27 | — | — | US | disclosed |
| EP-1551849-A1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | Pharmacia & Upjohn Company LLC (US) | 2005-07-13 | — | — | EP | disclosed |
| US-20040162279-A1 | Tricyclic tetrahydroquinoline antibacterial agents | ZOETIS SERVICES LLC | 2004-08-19 | — | — | US | disclosed |
| WO-2004031195-A1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-04-15 | — | — | WO | disclosed |
| EP-1398372-A1 | Lipid phosphate phosphatases and uses thereof for treating neuronal diseases | Universitätsklinikum Charité an der Humboldt- Universität zu Berlin (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-5910575-A | MONOCLONAL ANTIBODY WHICH BINDS TO (125)I-LABELED DERIVATIVES OF CORTISOL-3-CARBOXYMETHYLOXIME-HISTAMINE AND PREFERENTIALLY BINDS TO UNLABELED SYN ISOMER OVER UNLABELED ANTI ISOMER; FOR COMPETITIVE RADIOIMMUNOASSAY | IMMUNOTECH (FR) | 1999-06-08 | — | — | US | disclosed |
| US-4501699-A | ANTITUMOR ANTIBIOTICS OF THE DAUNORUBICINTYPE | LITTON BIONETICS, INC. (US) | 1985-02-26 | — | — | US | disclosed |
| US-4335121-A | TOPICAL ANTIINFLAMMATORY AGENTS | GLAXO GROUP LIMITED (GB) | 1982-06-15 | — | — | US | disclosed |
| US-4180679-A | HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092494-A1 | Tricyclic Tetrahydroquinoline Antibacterial Agents | QTRT1, QTRT2, NQO2 | ALDH1A1 1420/4885TDP1 1527/4885CYP2C19 184/4885 |
| US-20040162279-A1 | Tricyclic tetrahydroquinoline antibacterial agents | QTRT1, QTRT2, NQO2 | ALDH1A1 1420/4885TDP1 1527/4885CYP2C19 184/4885 |
| US-20100022524-A1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | QTRT1, QTRT2, NQO2 | ALDH1A1 1420/4885TDP1 1527/4885CYP2C19 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.